Stephen Johnston
MA, MD, PhD
Professor of Breast Cancer Medicine
👥Biography 个人简介
Stephen Johnston led the MonarchE adjuvant trial establishing abemaciclib plus endocrine therapy in high-risk HR-positive breast cancer. He has championed Ki67 as an enrichment biomarker for adjuvant CDK4/6 inhibitor use. His work transformed adjuvant treatment paradigms for proliferative HR-positive disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Stephen Johnston 的研究动态
Follow Stephen Johnston's research updates
留下邮箱，当我们发布与 Stephen Johnston（Royal Marsden NHS Foundation Trust）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment